SSTR5-AS1: A Potential Drug Target and Biomarker (G146336)

Target Name: SSTR5-AS1

NCBI ID: G146336

SSTR5-AS1

Other Name(s): SSTR5 antisense RNA 1

SSTR5-AS1: A Potential Drug Target and Biomarker

SSTR5 (short for double short RNA viral particle) is a family of non-coding RNAs that play a crucial role in the regulation of gene expression in various organisms, including humans. SSTR5 is expressed in a variety of cell types and is involved in the regulation of cell proliferation, apoptosis, and immune responses. The antisense RNA 1 (AS1) is a non-coding RNA that is generated by the DNA-protein complex during transcription. In this article, we discuss the potential implications of SSTR5-AS1 as a drug target and biomarker.

SSTR5-AS1 is a non-coding RNA that is highly expressed in various tissues and cell types, including the brain, heart, liver, and pancreas. It is composed of a single exon that is highly conserved across different species. SSTR5-AS1 has SSTR5-AS1 has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. SSTR5-AS1 has been shown to regulate the expression of genes that are involved in cell apoptosis, such as Bcl-2 and p53.

SSTR5-AS1 has also been shown to play a role in the regulation of cell proliferation. In various studies, SSTR5-AS1 has been shown to inhibit the expression of genes that are involved in cell proliferation, such as cyclin D1 and p21. This suggests that SSTR5-AS1 may have potential as a drug target for the treatment of cancer.

In addition to its potential role in cell proliferation and apoptosis, SSTR5-AS1 has also been shown to play a role in the regulation of the immune response. SSTR5-AS1 has been shown to regulate the expression of genes that are involved in the immune response. , such as T cell receptor subtype 5 (TCR5) and CD47. This suggests that SSTR5-AS1 may have potential as a biomarker for the treatment of immune-related diseases.

SSTR5-AS1 has also been shown to play a role in the regulation of cell migration. In various studies, SSTR5-AS1 has been shown to regulate the expression of genes that are involved in cell migration, such as vimentin and actinin. This suggests that SSTR5-AS1 may have potential as a drug target for the treatment of diseases that involve cell migration, such as cancer.

In conclusion, SSTR5-AS1 is a non-coding RNA that has been shown to play a role in the regulation of cell apoptosis, proliferation, and immune response. Its potential as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand the role of SSTR5-AS1 in various biological processes and to develop effective treatments based on this information.

Protein Name: SSTR5 Antisense RNA 1

The "SSTR5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSTR5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets